Immunity & Ageing | |
Defective pro-IL-1β responses in macrophages from aged mice | |
Anuja Mathew1  Douglas T Golenbock1  Katherine A Fitzgerald1  Vijay Rathinam1  Alejandro Ramirez1  | |
[1] Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, S6-862, 55 Lake Avenue North, Worcester, MA, 01655, USA | |
关键词: IL-1β; Inflammasome; NLRP3; Aged mice; Macrophages; Ageing; | |
Others : 815171 DOI : 10.1186/1742-4933-9-27 |
|
received in 2012-07-20, accepted in 2012-12-05, 发布年份 2012 | |
【 摘 要 】
Background
Cytokines regulated by the inflammasome pathway have been extensively implicated in various age-related immune pathologies. We set out to elucidate the contribution of the nod-like receptor protein 3 (NLRP3) inflammasome pathway to the previously described deficiencies in IL-1β production by macrophages from aged mice. We examined the production of pro-IL-1β and its conversion into IL-1β as two separate steps and compared these cytokine responses in bone marrow derived macrophages from young (6–8 weeks) and aged (18–24 months) C57BL/6 mice.
Findings
Relative to macrophages from young mice, macrophages from aged mice produced less pro-IL-1β after TLR4 stimulation with LPS. However upon activation of the NLRP3 inflammasome with ATP, macrophages from young and aged mice were able to efficiently convert and secrete intracellular pro-cytokines as functional cytokines.
Conclusions
Lower levels of IL-1β production are a result of slower and lower overall production of pro-IL-1β in macrophages from aged mice.
【 授权许可】
2012 Ramirez et al.; licensee BioMed Central Ltd.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
20140710060219182.pdf | 371KB | download | |
Figure 3. | 23KB | Image | download |
Figure 2. | 30KB | Image | download |
Figure 1. | 14KB | Image | download |
【 图 表 】
Figure 1.
Figure 2.
Figure 3.
【 参考文献 】
- [1]Krabbe KS, Pedersen M, Bruunsgaard H: Inflammatory mediators in the elderly. Exp Gerontol 2004, 39(5):687-699.
- [2]Bruunsgaard H, Pedersen M, Pedersen BK: Aging and proinflammatory cytokines. Curr Opin Hematol 2001, 8(3):131-136.
- [3]Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T: Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing Res Rev 2008, 7(2):83-105.
- [4]Ginaldi L, Loreto MF, Corsi MP, Modesti M, De Martinis M: Immunosenescence and infectious diseases. Microbes Infect 2001, 3(10):851-857.
- [5]Higashimoto Y, Fukuchi Y, Shimada Y, Ishida K, Ohata M, Furuse T, Shu C, Teramoto S, Matsuse T, Sudo E, et al.: The effects of aging on the function of alveolar macrophages in mice. Mech Ageing Dev 1993, 69(3):207-217.
- [6]Shaik-Dasthagirisaheb YB, Kantarci A, Gibson FC 3rd: Immune response of macrophages from young and aged mice to the oral pathogenic bacterium Porphyromonas gingivalis. Immun Ageing 2010, 7:15. BioMed Central Full Text
- [7]Chelvarajan RL, Liu Y, Popa D, Getchell ML, Getchell TV, Stromberg AJ, Bondada S: Molecular basis of age-associated cytokine dysregulation in LPS-stimulated macrophages. J Leukoc Biol 2006, 79(6):1314-1327.
- [8]Goldbach-Mansky R: Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1. Clin Exp Immunol 2012, 167(3):391-404.
- [9]Hooper-van Veen T, Schrijver HM, Zwiers A, Crusius JB, Knol DL, Kalkers NF, Laine ML, Barkhof F, Pena AS, Polman CH, et al.: The interleukin-1 gene family in multiple sclerosis susceptibility and disease course. Mult Scler 2003, 9(6):535-539.
- [10]Rader DJ: IL-1 and atherosclerosis: a murine twist to an evolving human story. J Clin Investig 2012, 122(1):27-30.
- [11]Kingsbury SR, Conaghan PG, McDermott MF: The role of the NLRP3 inflammasome in gout. J Inflamm Res 2011, 4:39-49.
- [12]Strowig T, Henao-Mejia J, Elinav E, Flavell R: Inflammasomes in health and disease. Nature 2012, 481(7381):278-286.
- [13]Dinarello CA: Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr 2006, 83(2):447S-455S.
- [14]Cavallone L, Bonafe M, Olivieri F, Cardelli M, Marchegiani F, Giovagnetti S, Di Stasio G, Giampieri C, Mugianesi E, Stecconi R, et al.: The role of IL-1 gene cluster in longevity: a study in Italian population. Mech Ageing Dev 2003, 124(4):533-538.
- [15]Jin C, Flavell RA: Molecular mechanism of NLRP3 inflammasome activation. J Clin Immunol 2010, 30(5):628-631.
- [16]Rathinam VA, Vanaja SK, Fitzgerald KA: Regulation of inflammasome signaling. Nat Immunol 2012, 13(4):333-342.
- [17]Bryant C, Fitzgerald KA: Molecular mechanisms involved in inflammasome activation. Trends Cell Biol 2009, 19(9):455-464.
- [18]Gomez CR, Karavitis J, Palmer JL, Faunce DE, Ramirez L, Nomellini V, Kovacs EJ: Interleukin-6 contributes to age-related alteration of cytokine production by macrophages. Mediators Inflamm 2010, 2010:475139.
- [19]Stout-Delgado HW, Vaughan SE, Shirali AC, Jaramillo RJ, Harrod KS: Impaired NLRP3 inflammasome function in elderly mice during influenza infection is rescued by treatment with nigericin. J Immunol 2012, 188(6):2815-2824.
- [20]Fulop T, Fortin C, Lesur O, Dupuis G, Kotb JR, Lord JM, Larbi A: The innate immune system and ageing: what is the contribution to immunosenescence. Open Longev Sci 2012, 6:121. 132